An upcoming FDA-AACR workshop on DPD deficiency testing
AACR (American Association for Cancer Research) shared a post on X:
“Considerations for dihydropyrimidine dehydrogenase (DPD) deficiency testing will be discussed in an upcoming FDA-AACR workshop. Cochairs AACR President Patricia LoRusso and Jennifer Gao discussed the workshop’s significance with the AACR blog.”
More posts featuring AACR.
Patricia LoRusso is Chief of Experimental Therapeutics and Associate Cancer Center Director for Experimental Therapeutics at Yale Cancer Center, where she also holds the Amy and Joseph Perella Professorship of Medicine (Medical Oncology). She is the President of the American Association for Cancer Research (AACR).
An expert in medical oncology, drug development, and early-phase clinical trials, Prof. LoRusso previously served at Wayne State University’s Barbara Karmanos Cancer Institute as Director of the Phase I Clinical Trials Program and the Eisenberg Center for Experimental Therapeutics.
Jennifer Gao, MD, is the Associate Director for Education at the FDA Oncology Center of Excellence and an oncologist based in Washington, D.C. Jennifer Gao specializes in breast cancer and hematologic oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023